Safety and Efficacy Study of CitraFleet (Sodium Picosulphate) as an Evacuating Treatment Prior to Colonoscopy.
Phase III, Multicenter, Randomized, Assessor-blind Study to Evaluate the Safety and Efficacy of CitraFleet (Sodium Picosulphate) as an Evacuating Treatment Prior to Colonoscopy.
Sponsor: Apices Soluciones S.L.
Listed as NCT01065857, this PHASE3 trial focuses on Subjects Undergoing a Complete Exploratory Diagnostic Colonoscopy for the First Time. and remains completed. Sponsored by Apices Soluciones S.L., it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jan 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Apices Soluciones S.L.
- Laboratorios Casen-Fleet S.L.U.
- Trial Form Support S.L.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Barcelona, Spain , Bilbao, Spain , Córdoba, Spain , Granada, Spain , Madrid, Spain , Murcia, Spain , Málaga, Spain , Oviedo, Spain , Pamplona, Spain , San Cristóbal de La Laguna, Spain and 3 more locations